RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Background/Aims: Helicobacter pylori (Hp) suppresses gastric acid secretion by repressing the expression of the H+, K+-adenosine triphosphatase (H+, K+-ATPase) and stimulating interleukin-1 (IL-1β; encoded by IL-1B). This study was aimed at evaluating the expression of the H+, K+-ATPase and IL-1β after Hp eradication. Methods: Two hundred twentyone subjects were categorized as Hp-negative (n=84) or Hppositive (n=137) according to the results of Hp tests (histology, CLO test, culturing, and serology). The mRNA expression levels of IL-1B and ATP4A (the gene encoding the α-subunit of H+, K+-ATPase) were measured in biopsy specimens from the gastric corpus using real-time polymerase chain reaction.
Results: The Hp-positive group had significantly higher IL-1B mRNA levels than the whole Hp-negative group and the intestinal metaplasia (IM)-negative subgroup. After Hp eradication, the difference between the Hp-negative and Hperadicated groups disappeared, including in the IM-negative subgroup. The IL-1B mRNA level did not significantly change from the baseline level. Within the gastric cancer (GC)/dysplasia subgroup, the IL-1B mRNA levels at 1, 2, 3–4, and ≥5 years after Hp eradication were significantly lower than the baseline level. The difference in ATP4A mRNA levels between the Hp-negative and Hp-positive groups was not significant at baseline, and the changes in the ATP4A mRNA levels after Hp eradication compared to the baseline levels in the whole group and subgroups stratified by the presence of IM and GC/dysplasia were not significant. Conclusions: Infection with Hp has an effect on the level of IL-1B mRNA in IM-negative subjects. The continuous reduction in the IL-1B mRNA level in patients with GC/dysplasia after Hp eradication contributes to the prevention of metachronous GC after Hp eradication.

참고문헌 (Reference)

1 World Medical Association, "World Medical Association Declaration of Helsinki : ethical principles for medical research involving human subjects" 9 : 105-109, 2002

2 Quante M, "The gastrointestinal tumor microenvironment" 145 : 63-78, 2013

3 Bair MJ, "Spontaneous clearance of Helicobacter pylori colonization in patients with partial gastrectomy : correlates with operative procedures and duration after operation" 108 : 13-19, 2009

4 Sung Min Baek, "Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea" 거트앤리버 소화기연관학회협의회 14 (14): 439-449, 2020

5 Hwang YJ, "Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication : a prospective study for up to 10 years" 47 : 380-390, 2018

6 Wang M, "Relation between interleukin-1beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori" 34 (34): 10-17, 1999

7 신재무, "Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors" 대한소화기 기능성질환∙운동학회 19 (19): 25-35, 2013

8 Kato S, "Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach" 23 (23): S258-S261, 2008

9 Nam SY, "Longterm follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer" 49 : 500-506, 2017

10 Kuipers EJ, "Long-term sequelae of Helicobacter pylori gastritis" 345 : 1525-1528, 1995